This inventor holds 23 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: Lipocine Inc., Other. Active years: 2021-2026.
Location History:
- Salt Lake City, UT (US) (2021 - 2024)
- West Jordan, UT (US) (2022 - 2024)
Company Filing History:
5 out of 48 
7 out of 834,411 Years Active: 2021-2026
Title: Innovations and Contributions of Inventor Kilyoung Kim
Introduction
Kilyoung Kim, an accomplished inventor based in Salt Lake City, Utah, has made significant strides in the field of pharmaceutical compositions. With a portfolio of 8 patents, his work primarily focuses on the development and methodology of testosterone therapy and related bioavailable compositions.
Latest Patents
Kilyoung Kim's latest patents include innovative formulations such as (17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions. These compositions are designed to be administered to mammals in need of testosterone therapy. The solid-state crystalline form of (17-β)-3-Oxoandrost-4-en-17-yl dodecanoate presents a melting point range of approximately 51° C. to 63° C., ensuring stability and bioavailability. Alongside this, his work on oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy introduces pharmaceutical compositions that allow for effective oral administration, highlighting the potential for treatment of conditions requiring testosterone.
Career Highlights
Throughout his career, Kilyoung Kim has consistently demonstrated a commitment to advancing therapeutic options through the innovative application of chemical research. His patents reflect a robust understanding of pharmaceutical sciences and the intricacies involved in hormone-related therapy. Each invention showcases his ability to address complexities in treatment methodologies, catering to a wide range of needs in the male population suffering from hypogonadism.
Collaborations
Kilyoung Kim has collaborated with esteemed colleagues like Nachiappan Chidambaram and Mahesh V Patel, contributing to a multidisciplinary approach in his research endeavors. Their collaboration has allowed for the pooling of expertise, fostering an environment ripe for innovation.
Conclusion
In summary, Kilyoung Kim's work continues to push the boundaries of pharmaceutical advancements. His patented inventions not only reflect technology's progress but also signify hope for those in need of effective hormone therapies. As he forges ahead with his research, the impact of his contributions will likely resonate within the medical community for years to come.